Chen, Q., Yin, H., Jiang, Z., He, T., Xie, Y., Mao, W., Han, J., Liu, S., Lou, W., Wu, W., Habib, J. R., Yu, J., Liu, L., Pu, N.

Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer

27 de March de 2024 by Chen, Q., Yin, H., Jiang, Z., He, T., Xie, Y., Mao, W., Han, J., Liu, S., Lou, W., Wu, W., Habib, J. R., Yu, J., Liu, L., Pu, N.

Background
The role of CD161 expression on CD8+ T cells in tumor immunology has been explored in a few studies, and the clinical significance of CD161+CD8+ T cells in pancreatic ductal adenocarcinoma (PDAC) remains unclear. This study seeks to clarify…